Zix Corporation (ZIXI) Retains Allen & Company to Review Strategic Alternatives
Up)
Zix Corporation (Nasdaq: ZIXI) has retained Allen & Company LLC to assist ZixCorp's Board of Directors in investigating strategic alternatives for maximizing the value of the Company's e-Prescribing business. This strategic review may result in a partnership, joint venture, the sale of some or all of its e-Prescribing assets or a similar transaction.
No decision has been made to enter into any transaction at this time and there can be no assurance that the Company will enter into such a transaction in the future. It is ZixCorp's policy not to comment on any specific discussions or any potential corporate transactions unless and until it enters into a definitive agreement with respect to such a transaction.
Zix Corporation is involved in email encryption and payor sponsored e-prescribing services. [SM]
No decision has been made to enter into any transaction at this time and there can be no assurance that the Company will enter into such a transaction in the future. It is ZixCorp's policy not to comment on any specific discussions or any potential corporate transactions unless and until it enters into a definitive agreement with respect to such a transaction.
Zix Corporation is involved in email encryption and payor sponsored e-prescribing services. [SM]
You May Also Be Interested In
- Syngenta (SYT) settles atrazine litigation; will pay $105M in deal
- Euroseas (ESEA) commences 13.9M rights offering
- CNH Global N.V. (CNH) Stops Doing Business with Iran
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
